John Selig is a Managing Director at Woodside Capital Partners. He advises healthcare companies on M&A, licensing and finance strategy.
Prior to joining Woodside, he was a Partner at Keelin Reeds Partners, a healthcare management consulting firm, where he advised dozens of VC-backed and small cap biopharmaceutical, medical device and diagnostics companies on M&A and licensing strategies, portfolio management, valuation and strategic direction. While at KR, John led a partnership deal term benchmarking effort and has extensive experience in applying that data to yield market-value deal terms for dozens of assets, using the results to inform product strategy and to provide ongoing support during deal negotiations. John also combined his expertise in valuation, deal term benchmarking and decision analysis with his background in law to help companies make optimal decisions in litigation and settlement.
Previously, John was a senior consultant with Strategic Decisions Group, a global management consulting firm, where he advised numerous Fortune 500 companies in healthcare and other industries on valuation, business strategy and M&A. Prior to consulting, John was an attorney with Weil, Gotshal & Manges LLP where he focused on M&A and corporate finance.
John holds a JD from Stanford Law School, where he was an associate editor of the law review, and a BA, magna cum laude, from Brown University, where he was a member of Phi Beta Kappa.